Sciety is a leading life science investment company in the Nordic region, dedicated to investing in the most promising businesses in the industry. Our goal is to help companies reach their full potential and make a lasting impact on tomorrow’s healthcare. But we are not just any investor – we are a long-term partner with a deep understanding of the life science and healthcare industries.
We bring more than just financial support to the table. Our team is composed of experienced researchers, clinicians, entrepreneurs, and business people who bring a wealth of industry knowledge and expertise to the companies we invest in. We are here to support your growth, whether it be through introductions to potential customers, partners and team members, or operational and strategic advice.
Our initial investment tickets range from 1 million to 15 million EUR, with follow-on investments of up to 30 million EUR. Our goal is to be a true partner to our portfolio companies, helping them succeed and grow over the long term.
We are proud of the impact we have made thus far, having invested more than 1 billion SEK in 29 companies since our start in 2016. 10 of these companies have since been acquired or listed on the stock exchange, demonstrating our track record of success.
“Partnering with Sciety in our capital raising was an effective way forward. Bringing a drug candidate from innovation to implementation requires capital, and thanks to Sciety we could continue this work without losing momentum. Sciety led the round with the highest professionalism and dedication, and their expertise in life science, business and finance was very useful. If you run a life science company and get the opportunity to work with Sciety, take it!”
Marika Nestor
CEO and co-founder, Akiram Therapeutics
At Sciety, we are passionate about driving innovation, advancing research, and building great companies. As part of our ongoing efforts to support researchers and business managers in life science and health tech, we regularly host seminars where we provide insights, expert tips, and practical advice. Join our newsletter to stay up to date with our latest news and receive exclusive invitations to our seminars.
CASE STUDY | Capitainer, a medtech company specialising in at-home blood and urine sampling technologies, needed to raise external capital to make their vision a reality. The collaboration with Sciety resulted in an investment that enabled Capitainer to scale up production and increase sales. Capitainer’s long-term partnership with Sciety has also been pivotal in their strategic expansion into the US market.
From clinical validation phase to expansion phase.
From late preclinical phase to Phase II clinical trials. All therapeutic areas.
From clinical validation to expansion phase. All indications.
From pilot phase to expansion phase. Solutions for healthcare and research.
From early sales to expansion phase. Preventive care and healthcare.
Want to receive our latest updates and insights? Sign up and we will keep you posted.
Are you on to something big? If you are a company working within life science or digital health and based in the Nordics – we would love to hear from you. Please drop us an email at financing@sciety.se
Sending a pitch deck along with your email is optional, but this makes it easier for us to determine if we are a good match and speeds up our response time.